(CMV) in the pulmonary tissue ofpatients with AIDS8 and human herpes virus 6 associated interstitial pneumonitis in bone marrow transplant patients.9 Although a number of features of this suggest that EBV may be pathogenic, it is important to note that, because of the presence of immunosuppression, it remains possible that the EBV replication was coincidental rather than causal to the graft failure.
In April 1993 she underwent left single lung transplantation. The donor was a 28 year old female non-smoker with no history of cardiopulmonary disease. Total ischaemic time for the procedure was five hours. In the early postoperative period the patient required one course of methylprednisolone (1 g for three days) for acute rejection, and antibiotics for Staphylococcus aureus cultured from sputum. She made a complete recovery.
In April 1994 her exercise tolerance was excellent. She led a full active life and planned marriage. At her annual assessment FEV, was 2.2 1 (75% predicted) and FVC 2.5 1 (74% predicted). Immunosuppression consisted of triple therapy with whole blood cyclosporin levels of 150-250ng/ml (parent compound), azathioprine 1 mg/kg, and prednisolone (8 mg at one year).
In Elective lower segment Caesarean section was performed at 38 weeks gestation under a combined epidural-spinal anaesthetic and a healthy male infant was delivered with a birth weight of 2.56 kg. He was bottlefed and at nine months is thriving and developing normally.
There were no postoperative complications. Following delivery there was symptomatic improvement but her spirometric values continued to decline and at eight weeks postpartum the FEV, was 1.26 1 and FVC 1.83 1.
She was hypertensive and amlodipine 5 mg was started with good effect. The patient and her husband have used the sheath and spermicidal jelly for contraception.
In view of the continuing deterioration she was converted to tacrolimus but, despite adequate blood levels (10-15 mg/ml), her lung function tests continued to decline so she underwent total lymphoid irradiation following which her condition has stabilised.
The patient continues to lead an independent life and is able to care for her child.
Discussion
Little information is available about pregnancy in single lung transplant recipients and this is the first case to be reported.
Pregnancy in "normal" women does not usually result in major changes in respiratory function tests and any decline in those of lung transplant recipients should therefore be viewed with suspicion. There should be a low threshold for the diagnosis of graft dysfunction, but management is hampered by a reluctance to perform chest radiography and invasive procedures such as bronchoscopy and transbronchial biopsies during pregnancy.
In renal transplant recipients changes in cyclosporin levels (caused by increasing blood volume, reduced haematocrit, and impairment of hepatic clearance) have been recorded in pregnancy.45 Cyclosporin levels must be monitored carefully and doses adjusted accordingly to maintain therapeutic levels. Cyclosporin nephrotoxicity, which may be present before pregnancy, and hypertension are prevalent in transplant recipients and may predispose to pre-eclamptic toxaemia (PET).6
The effect of immunosuppressive drugs on the fetus and neonate have been studied in the children of renal and heart transplant recipients. There appears to be no significant effect on fetal immunity7 and there is low risk of teratogenicity with these agents.8 However, the incidence of prematurity and fetal growth retardation in children of renal transplant recipients is high. '9 Chronic rejection/obliterative bronchiolitis is a serious long term complication of lung transplantation. We do not know if the risk is increased in pregnancy or the postpartum period. More aggressive investigation and immunosuppression therapy may be required to reduce long term graft dysfunction, but this has to Comrs be balanced against the attendant risks of life threatening infections and possible treatment with antibiotic regimens that may be teratogenic. The five year survival rate following single lung transplantation is 40%o,iO and there is a significant risk that a mother will not live to see her child reach maturity. 
